Location History:
- Phoenix, AZ (US) (1993 - 1998)
- late of Glendale, AZ (US) (2004)
- Glendale, AZ (US) (1996 - 2007)
Company Filing History:
1 out of 416 
1 out of 8 
11 out of 832,812 Years Active: 1993-2007
Title: The Innovative Contributions of Morris A Mann
Introduction
Morris A Mann is a notable inventor based in Glendale, AZ, who has made significant contributions to the field of neurological treatments. With a total of 13 patents to his name, Mann's work focuses on innovative compositions that address various neuropsychiatric disorders. His research and inventions have the potential to improve the quality of life for many individuals suffering from these conditions.
Latest Patents
Mann's latest patents include groundbreaking developments in the treatment of neurological disorders. One of his notable inventions is a non-stoichiometric clathrate of lipid and sulfur, which has been shown to effectively stabilize nerve cell membranes. This compound has proven useful in treating a variety of neuropsychiatric disorders, including addiction, depression, autism, and Tourette's syndrome. Another significant patent involves sublingual compositions comprising thymosin fraction 5, which describes methods and compositions that allow for the sublingual absorption of peptides through oral administration. The peptides are stable at room temperature, and both liquid and tablet formats for the sublingual approach have been demonstrated.
Career Highlights
Throughout his career, Morris A Mann has worked with various companies, including Ausimont S.p.a. His innovative approach to research and development has led to advancements in the treatment of neurological disorders, showcasing his dedication to improving patient outcomes.
Collaborations
Mann has collaborated with several professionals in his field, including Giovanni Pantini and Cheryl R Mitchell. These collaborations have contributed to the success of his research and the development of his patented inventions.
Conclusion
Morris A Mann's contributions to the field of neurological treatments through his innovative patents highlight his commitment to addressing complex medical challenges. His work continues to pave the way for advancements in the treatment of neuropsychiatric disorders.